Survival and morbidity in transfusion-dependent thalassemic patients on subcutaneous desferrioxamine chelation. Nearly two decades of experience. Academic Article uri icon

Overview

publication date

  • June 30, 1998

Research

keywords

  • Blood Transfusion
  • Deferoxamine
  • Iron Chelating Agents
  • beta-Thalassemia

Identity

Scopus Document Identifier

  • 0031876334

Digital Object Identifier (DOI)

  • 10.1111/j.1749-6632.1998.tb10524.x

PubMed ID

  • 9668587

Additional Document Info

volume

  • 850